Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: Postdural Puncture Headache, Sphenopalatine Ganglion Block

In brief

The investigators are attempting to determine a less invasive method of treatment for postdural puncture headaches that can occur after regional anesthesia. The investigators will be evaluating the relief of headache with those subjects receiving treatment with a sphenopalatine ganglion block with bupivacaine versus placebo, evaluating the incidence of epidural blood patch, pain score of headache at 1 hour, then 24, 48, and 72 hours lower with post study treatment versus placebo, and potential side effects of those patients receiving study therapy as well as epidural blood patch.

Key facts

Study ID

NCT02181205

Run by

Wake Forest University Health Sciences

People needed

0

Starts

2014-11-01

Expected to finish

2016-12-31

Last updated by the study team

2017-11-08

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• American Society of Anesthesiologists assigned class I-III
• age >/= 18 years
• experiencing a postdural puncture headache within 7 days of neuraxial analgesia rated >3/10 pain score

You may not qualify if…

• allergy to study medications <18 years of age pain score on presentation </=3/10 for headache

Where it is running

• Novant Health Forsyth Medical Center — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.